Colluletal Valuation - Sunatna,y SiocA I'rice Assunm1,,iv,'s us o~ 30-Aug-SI l2nron $35.50 I (:osuapaj $12.69 I Iii, Lilly $19.32 BA Chase Coni ass Total 80.0% 80.0% 80.0% 70.0% E~IiiI~~~. 80.11% Original LOC Outslaiidlng Current urv Mkt Val. Collateral Collateral I~eq. Excess (Deficit) $40,000,000 $15,000,000 $5,579,392 $2,689,000 43.0% $12,965,126 56.974.240 $5,990,886 81.0% $3,318,302 53.361.250 ($42,948) SI 0,000,000 $3,489,871 54.5% $6,406,089 53.324.871 $10,083,697 EI~60 73.1% $13,800,000 $36,489,517 S 13.660.361 $5,947,938 Borrowluag Poweri ~!S7~I7.P~ I - ~$.4~,94P) :, ~iti~otiti~I ~ ~. .1 .'.. S4,5I~4,76I I I . - - Original LOC Outstanding Available Linel Compaq Eli Lilly EOTI Tcw $750,000 $1,000,000 50 50 $500,000 so $0 $0 $2,250,000 SI) $750,000 $1,000,000 $500,000 $0 $2,250,000 100.0% 100.0% 100.0% * Compass LOC has 80% L lVoii all liquid assets l,el~l as collateral. hue cit ephion is ihe Sanders' aeroum uu'hui, C(,nSL.SIS of illiqead assets that Con, puss offers the lesser of 30% Liv or Slinna LOCA)tOttaO 818)2002 GOVERNMENT EXHIBIT 24226 CrimNo H 04-0025 LTV S5,OOti,000 81.4% $6146.1 IS $~QAiQQ (103,885) m r) 0 0 0 0 t.J '.0 ~C) (50 -o = C rs (A C04 oH 04 -TI- Allocation of Collateralfor Secured LOC BA Chase Cons ass IU 17.5% 92.4% 72.7% 32.5% 7.6% 00% o 0% 0 0% 27.3% diversified 0.0% 00% 0.0% 0.0% 0.0% 0.0% r I Collateral Valuation - Summary SiocA Price Assumptions as of I 30-Aug-01 FOiT $20.45 E.iron $35.50 TCW - Select $15.47 Compaq $12.69 TCW - Aggr. $11.49 Eli Lilly $79.32 TCW - Small . $17.86 BA I Conmoass I LTV Original LOC outstanding Current LTV MkI Val. Collateral Collateral Req. Excess (Deficit) 80.0% FIJ I Total I AlP KLL 80.0% 70.0% $10,000,000 $1,000,000 $6,973,000 $670,000 82.2% $8,485,826 $8.7 16.250 ($230,424) 75.5% $887,500 $837.500 $50,000 $2,000,000 $2,190,352 62.4% $3,512,587 200,000 $13,000,000 $9,833,352 $2,523,500 $12,885,913 S9.553.750 $19,576 Dorrowing roweri Enroit Coiuipaq Ela Lilly FOJT TCW I~.4~1)I 1000% $~lQA~9Q I *;~:,; '~ 200,900 ~ . S9,~76 I 100.0% LOC 010830 8I8I~OO2 Tot~il all $1 2.356.852 C/) til C) C C C C C t~J C (bo .fl ~ ~ - (1 a- fl-i -In '11 - 0 Allocation of collateral BA Coni ass EU 25.1% 100.0% 16.9% 00% 18.9% 0.0% diversified 1.2% 0.0% 37.9% 0.0% Collateral Valuation Bank a/America Stock Price assumptions 30-Aug-or Enron $35.50 TOW. Select SIS.47 Compaq S12.69 TCW.Aggr. SIl.49 Eli Lilly $7922 TOW - Small $17.86 EOTT $20.45 * 0.0~Ll0~ens a incia tine ..~in *. a.. Outstanding Loan Balance SS.579..392 Collateral Pled ed Shares Value Enron Corp. 246,445 $8,748,798 Compaq Computer 332.256 Total Market Value of Collateral S 12.965.126 Less: Collateral Required (80% LTV) 43.030/o S6.,974.240 ~ Excess (Deficit) Collateral 35.990.886 Borrowing Power $4,792,709 Available to Borrow S4,792.709 Outstanding Loan Balance S6.973,OO0 Collateral Pledged Shares Value Compaq 113,064 $1,434,782 Eli Lilly & Co. 20,220 S 1,603,850 EOIT Energy Parmers 5,000 S 102.250 TOW Galileo Select Equities 131,738 52,037,987 TOW Galileo Ag~essive Growth 3 7.949 $436,034 TOW Small Cap Growth 41,485 $740,922 Enron Corp. (includes additional 25,000 shares) 60,000 52.130.000 Total Market Value of Collateral 58,485.826 Less: Collateral Required (LTV 80%) 82.17% S8,716,250 Excess (Deficit) Collateral (S230,424) Borrowing Power SO Available to Borrow SO Confidential Treatment Rcqueste~ under FOIA LAY-SEC. 1 00000023 1 67.5% 32.5% 100.0% 16.9% 18.9% 1.2% 24.0% 5.1% 8.7% 25.1% 100.0% LOC.0t0830 8/8/2002 Collateral Valuation Bank of Amerzca Outstanding Loan Balance LIii~i~oo.ooo Collateral Pledged Shares Value Eriron Corp. 173,130 S6,146,ll5 Total Market Value of Collateral S6,146.I 15 Less: Collateral Required (80% LTV) 81,4% S6,250,000 Excess (Deficit) Collateral (S103.885) ~Borrowing Power SO Available to Borrow SO S750.000 Line of Credit (Unsecured) L'NIO Kenneth L. & Linda P. Lay Outstanding Loan Balance L0C010830 8/8/2002 SO Confidential Treatment Requested under FOIA LAY-SEC-i 000000232 Collateral Valuation Chase 30-Aug-01 Stock Price Assumptions Enron 535.50 Comoa~ S 12.69 S 15.0 Million Non ?urnose Credit Line [ STOCK Symbol CertiL No. Shares Enron Corp ENE Chase Acct 3,936 Enron Corp ENE Chase ACCt 82.388 Total ENE 86..324 Value S 139728 S 292474 S 3.064.502 CPQ BB125523 20.000 S 253.800 Personal Total CPQ 20.000 S 253,800 7.6% Total Value of Collateral S 3.318.302 LTV 80% AVAILABLE BALANCE ~. 488 727 Funded (S2.689.000Y REMAINING BALANCE -(S200,Z74~' LOC.. 010830 8/8/2002 LAY-sEC.. I 000000233 Compaq Ownership] Personal Personal 92.4/. Confidential Treatment Requested under FOIA Collateral Valuation Compass 30-Aug-O1~ IS tack Pnce Assum~uon Enron $35.50 Eli Lilly S79.32 $10.0 Million Non Purpose Credit Line STOCK Symbol Certif. No. Shares Ownership Eli Lilly LLY ~C24922 5,000 Personal Eli Lilly LLY CNY1S3SO 5 000 Personal Total LLY 10,000 793,200 Enron Corp ENE HC119322 7,690 Personal Enron Corp ENE HCt 19285 22.052 Personal Enron Corp ENE HC119286 1,751 Personal Enron Corp-Split ENE HC164652 1,751 Personal Enron Corp ENE HC119359 4,521 Personal Enron Corp-Split ENE HC164653 4,521 Personal Enron Corp ENE HC1 19360 7,792 Personal Enron Corp ENE HCI 27094 9 4.40 Personal Total ENE 59,515 2,112,889 TOTAL $ 2,906,089 LTV 80% AVAiLABLE BALANCE S2324.871 Funded ~ REMAINING BALANCE (S1A165.000 Additional Collateral Sanders Moms Hams (30% LTV. 27.3% 72.7% capped at $1.000.0001 Total $ 3,500,000 LTV 30% AVAILABLE BALANCE $ 1,000,000 Funded ~ . -' *SO~ REMAINING BALANCE S1.000,000 Confidential Treatment Requested under FO! \ LAY~SEC.. 1 000000234 LOC...0 10830 81812002 Personal - Secured L CC (SOOG) Enron LOC Pw BA Chase C ainpass Total 500 500,000 4,793 9,146,000 (43) 1,900.000 (165) 400,000 5.085 Personal - Unsecured LOC (SOOO) BA 1,000 (increasing from S750,000: should be effective next week) Chase 1,000 (increasing from S750,000: should be effective next week) Compass 500 Total 2,500 Partnership - LOC ($000) Now BA Pw 257 (additional collateral should be in place early next week) 7 waiting for the dust to clear but it is positive 257 at least this much When shares settle at BA assuming yesterdays price of$4&34 BA~ (230) Pw (230) Confidential Treatment Requested under FOJA LA Y-SE~1 000000235